Who we are
How we are funded
Governance and structure
Reports and statements
Working with us
Support for MRC researchers
Advise & Connect: Covid-19
Rare disease translational challenges
Current funding opportunities
IP management and technology transfer
Working at LifeArc
Benefits and rewards
Students and fellows
How to apply
Reports and publications
How we're making life science life changing
We're investing £1.3bn by 2030 to solve complex healthcare challenges.
Our aim is to accelerate the progression of affordable and accessible solutions to tackle infectious diseases around the world.
We’re investing up to £100m to tackle neurodegenerative conditions.
Find out how we’re accelerating scientific innovation for people living with bronchiectasis and cystic fibrosis and protecting people from COVID-19.
We’re investing over £100m to accelerate rare disease treatments and diagnostics